Hypertension Clinical Trials

Find Hypertension Clinical Trials Near You

Investigation of the Relationship Between Dietary Nitrate and Oral Microbiota in Children With Primary Hypertension

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Children and adolescents with primary hypertension (high blood pressure without an underlying secondary cause) are at increased risk of cardiovascular disease in adulthood. Recent research suggests that not only the heart and blood vessels, but also the bacteria living in the mouth may play a role in blood pressure regulation. Certain oral bacteria can convert nitrate from food into nitrite and then into nitric oxide, a substance that helps blood vessels relax. If this nitrate-nitrite-nitric oxide pathway is impaired, blood pressure may rise. This study aims to investigate the relationship between oral microbiota, salivary nitric oxide reductase activity and blood pressure in children and adolescents with primary hypertension compared with healthy peers. We will recruit participants aged 10-18 years who have a diagnosis of primary hypertension and an age- and sex-matched control group without hypertension. All participants will undergo a non-invasive oral and dental examination and standardized blood pressure measurements. Saliva samples will be collected to measure pH, flow rate, nitrate and nitrite levels, total protein, lysozyme activity and to analyze the composition of oral bacteria using modern DNA-based techniques. Participants and/or their parents will also complete brief questionnaires about diet and general health. No medication or dietary supplement will be given as part of the study, and no additional blood samples will be taken beyond routine clinical care. The main risk is minimal discomfort related to oral examination and saliva collection. There is no guaranteed direct benefit for participants; however, the results may help us better understand how oral bacteria and salivary nitric oxide pathways are linked to high blood pressure in young people. This knowledge may support the development of new non-invasive strategies for early detection and prevention of hypertension in the future.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 18
Healthy Volunteers: t
View:

• Applied to the Istanbul University Faculty of Medicine, Department of Pediatric Nephrology,

• Between the ages of 10 and 18,

• Diagnosed with primary hypertension,

• Clinically excluded from secondary hypertension or heart failure,

• No systemic or chronic disease other than hypertension,

• No periodontal disease, dental infection, or oral mucosal disease,

• Not taking regular antihypertensive or other medications for a chronic disease,

• Not having received antibiotic treatment in the last 3 months,

• Patients who have not used mouthwash in the last 3 months,

• Have no allergies to nitrate-rich foods,

• Both male and female patients will be included.

Locations
Other Locations
Turkey
Istanbul University Faculty of Dentistry
RECRUITING
Istanbul
Contact Information
Primary
Yelda Kasimoglu Assoc. Prof.
yelda.kasimoglu@iu.edu.tr
+90 533 623 39 78
Time Frame
Start Date: 2026-04-15
Estimated Completion Date: 2027-01-15
Participants
Target number of participants: 48
Treatments
Patients with primary hypertension
This group includes adolescents aged 10-18 years who have been clinically diagnosed with primary hypertension based on repeated office blood pressure measurements according to pediatric hypertension guidelines. Participants will undergo standardized assessments including oral examination, blood pressure measurements, salivary collection, and laboratory analyses. Laboratory procedures include: oral microbiota profiling through 16S rRNA gene sequencing, quantification of nitrate-reducing bacterial activity, measurement of salivary pH, total protein concentration, and lysozyme activity. No therapeutic intervention will be administered. All procedures are observational and aim to characterize microbial and biochemical markers associated with primary hypertension.
Healthy controls
This group includes healthy adolescents aged 10-18 years with no history of primary or secondary hypertension, chronic systemic disease, or regular medication use affecting cardiovascular or oral microbiome physiology. Participants will undergo standard clinical assessments identical to the hypertension group, including oral examination, salivary collection, and blood pressure measurement. Laboratory procedures will include salivary microbiota analysis (16S rRNA sequencing), assessment of nitrate-reducing bacterial activity, salivary pH, total protein concentration, and lysozyme activity. This cohort serves as the normative comparison group to evaluate microbial and biochemical differences associated with primary hypertension. No intervention will be administered.
Related Therapeutic Areas
Sponsors
Leads: Yelda Kasımoğlu
Collaborators: Istanbul University Scientific Research Projects Coordination Unit- Pending

This content was sourced from clinicaltrials.gov